NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC ...

NEW YORK - Piper Sandler Companies (NYSE: PIPR), a prominent investment bank, and BC Partners Credit have announced a strategic alliance aimed at enhancing debt capital market access for financial ...

On Monday, Piper Sandler maintained an Overweight rating on shares of Yeti Holdings Inc. (NYSE:NYSE:YETI), with a steady price target of $55.00. The firm expressed confidence in the company's ...

Piper Sandler analyst Brian Mullan maintained a Hold rating on Brinker International (EAT – Research Report) today and set a price target of $97.00. The company’s shares closed last Friday at ...

Fastly (NYSE:FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped its price target on the content delivery company after it reported ...

NEW YORK, October 18, 2024--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brian Vescio as a managing director and head of ...

Piper Sandler analyst Thomas Champion reiterated a Hold rating on Booking Holdings (BKNG – Research Report) today and set a price target of $4,900.00. The company’s shares closed yesterday at ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brian Vescio as a managing director and head of structured products trading to the fixed ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brian Vescio as a managing director and head of structured products trading to the fixed income ...

Piper Sandler initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $18 price target The company is is pioneering development of regulatory RNAs as a novel therapeutic ...

Piper Sandler raised the firm’s price target on Itron (ITRI) to $119 from $110 and keeps a Neutral rating on the shares following “solid” Q3 results. According to the firm, EBITDA exceeded ...